[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Haematology](https://durgical.com/en/haematology/) › [Myeloid neoplasms](https://durgical.com/en/haematology/areas/myeloid/) › MDS/MPN overlap: CMML, JMML and atypical CML

# MDS/MPN overlap: CMML, JMML and atypical CML

- Look-alikes compared

Some marrow cancers both overproduce and produce badly. Recognising the overlap explains why the count is high, the cells look wrong and the [spleen](https://durgical.com/en/anatomy/spleen/) is big.

Updated Nov 15, 2026

## Key points

- MDS/MPN = too many cells and badly made cells at once, blasts under 20%.
- CMML: persistent monocytes ≥ 0.5 × 10⁹/L and ≥ 10%; TET2, SRSF2, ASXL1.
- JMML: young child, RAS pathway, high HbF, monosomy 7; transplant for most.
- Atypical CML: dysplastic neutrophils, BCR::ABL1 negative, SETBP1.
- Transplant is the only cure; hypomethylating agents and [hydroxycarbamide](https://durgical.com/en/pharmacology/hydroxycarbamide/) control.

On this page

- The basics Key points
- What it is
- How to think about it
- The difference in one line
- The overlap neoplasms side by side
- How it is confirmed
- Common traps
- Elsewhere in DurgiPedia

- Clinical In clinical practice

- Study Test yourself

- Connections Connections

## What it is

Myelodysplastic/myeloproliferative neoplasms are clonal marrow diseases with features of both halves at once: high counts and a big spleen (the MPN side) together with dysplasia and often cytopenias of other lines (the MDS side), with fewer than 20% blasts. Chronic myelomonocytic leukaemia (CMML) is the commonest, in older adults; juvenile myelomonocytic leukaemia (JMML) is its childhood counterpart, driven by the RAS pathway; atypical CML (renamed MDS/MPN with neutrophilia in the 2022 WHO classification) makes too many dysplastic neutrophils without BCR::ABL1; and MDS/MPN with SF3B1 mutation and thrombocytosis combines ring sideroblasts with a high platelet count.

## How to think about it

Think of one marrow with a stuck accelerator and a faulty assembly line. The accelerator (often a RAS-pathway or JAK2 signal) floods the blood with one cell type; the assembly line (splicing and epigenetic genes such as SRSF2, SF3B1, TET2, ASXL1) makes those cells badly. Name the overlap by which cell floods the blood: monocytes (CMML, or JMML in a small child), dysplastic neutrophils (atypical CML) or platelets with ring sideroblasts (MDS/MPN-SF3B1-T).

## The difference in one line

- CMML: persistent monocytes of at least 0.5 × 10⁹/L and at least 10% of white cells under the 2022 classifications (older criteria used 1 × 10⁹/L), with fewer than 20% blasts and no BCR::ABL1.
- CMML is split into a dysplastic type (lower white count, cytopenias) and a proliferative type (white count of 13 × 10⁹/L or more, big spleen, skin and serous infiltrates); TET2, SRSF2, ASXL1 and RAS mutations are typical.
- JMML: children usually under 6, often infants; monocytosis, big [liver](https://durgical.com/en/anatomy/liver/) and spleen, rash, high fetal haemoglobin, monosomy 7 in some; driven by PTPN11, NRAS, KRAS, NF1 or CBL, with links to [Noonan syndrome](https://durgical.com/en/conditions/noonan-syndrome/) and [neurofibromatosis](https://durgical.com/en/conditions/neurofibromatosis/) type 1.
- Atypical CML: high white count with dysplastic neutrophils and at least 10% immature granulocytes, few monocytes and basophils, no BCR::ABL1; SETBP1 and ASXL1 mutations are common; it differs from CML (basophilia, BCR::ABL1) and chronic neutrophilic leukaemia (CSF3R, mature cells without dysplasia).
- All can progress to AML; the risk is highest with adverse mutations such as ASXL1 and with rising blasts.
- Allogeneic stem cell transplant is the only curative treatment; hypomethylating agents and cytoreduction with hydroxycarbamide control disease in others.

## The overlap neoplasms side by side

| Feature | CMML | JMML | Atypical CML | MDS/MPN-SF3B1-T |
| --- | --- | --- | --- | --- |
| Typical patient | Older adult, more often men | Infant or young child, sometimes with Noonan or NF1 | Older adult | Older adult |
| The cell that floods the blood | Monocytes | Monocytes with immature myeloid cells and nucleated red cells | Dysplastic neutrophils and their precursors | Platelets |
| Key genetics | TET2, SRSF2, ASXL1, RAS | PTPN11, NRAS, KRAS, NF1, CBL; monosomy 7 | SETBP1, ASXL1; BCR::ABL1 negative | SF3B1 with JAK2 V617F in many |
| Other clue | Big spleen, skin infiltrates, autoimmune features | High fetal haemoglobin, rash, GM-CSF hypersensitivity | Few basophils and monocytes | Ring sideroblasts in the marrow, anaemia |
| Treatment principle | Observation if low risk; hypomethylating agent or hydroxycarbamide; transplant if fit and high risk | Allogeneic transplant for most; some CBL and NRAS cases regress on their own | Transplant if fit; hypomethylating agent or hydroxycarbamide otherwise | Treat anaemia (ESA, [luspatercept](https://durgical.com/en/pharmacology/luspatercept/)) and thrombosis risk |

## In clinical practice

- An older adult with persistent monocytosis, a big spleen and a low platelet count, without infection or inflammation to explain it, needs a smear and marrow for CMML.
- Reactive monocytosis ([tuberculosis](https://durgical.com/en/conditions/tuberculosis/), endocarditis, recovery from neutropenia, steroids) is far more common than CMML and is excluded first.
- A toddler with a big spleen, rash, monocytosis and a very high fetal haemoglobin is JMML until proven otherwise; café-au-lait spots or Noonan features add weight.
- A high white count with dysplastic, poorly granulated neutrophils and no basophilia should not be labelled CML until BCR::ABL1 testing is negative and atypical CML is considered.
- Autoimmune and inflammatory conditions (vasculitis, polychondritis, arthritis) accompany CMML in a minority of patients.

## How it is confirmed

- Repeat counts to show the monocytosis persists; smear review for dysplasia, promonocytes and blasts.
- BCR::ABL1, plus PDGFRA, PDGFRB and FGFR1 rearrangements when eosinophils are high, to exclude neoplasms with targeted treatment.
- Marrow aspirate and biopsy with karyotype and a myeloid gene panel (TET2, SRSF2, ASXL1, RAS, SETBP1, SF3B1, JAK2).
- Flow cytometry of blood monocytes: an excess of classical monocytes supports CMML over reactive monocytosis.
- JMML: fetal haemoglobin for age, karyotype for monosomy 7 and RAS-pathway gene testing, including germline testing for Noonan, NF1 and CBL syndromes.

## Common traps

- **Calling persistent monocytosis in an older adult reactive without a smear**: CMML can hide behind a normal total white count
- **Diagnosing CML from a high white count and big spleen alone**: atypical CML and CMML are BCR::ABL1 negative and do not respond to TKIs
- **Missing JMML because a toddler's big spleen and fever look like infection**: a very high fetal haemoglobin and monocytosis point the other way
- **Treating every overlap neoplasm as MDS**: the proliferative features (high counts, big spleen) need cytoreduction too
- **Forgetting PDGFR rearrangements when eosinophils are high**: those neoplasms respond very well to [imatinib](https://durgical.com/en/pharmacology/imatinib/)

## Test yourself

Think of the answer, then tap the question to see it.

## A 74-year-old man has had monocytes around 2 × 10⁹/L for six months, a spleen tip and mild thrombocytopenia; no infection is found. Which diagnosis and which test next?

Suspected CMML: marrow aspirate and biopsy with karyotype and a myeloid gene panel (TET2, SRSF2, ASXL1), plus BCR::ABL1 to exclude CML.

## A 14-month-old has a big spleen, a rash, monocytosis and a fetal haemoglobin far above that expected for age. Which disease is likely, and what is the usual curative treatment?

Juvenile myelomonocytic leukaemia, a RAS-pathway neoplasm; allogeneic stem cell transplant cures most patients.

## Why does a patient with a high white count, dysplastic neutrophils and no basophilia fail to respond to a tyrosine kinase inhibitor given for 'CML'?

It was atypical CML, which lacks BCR::ABL1; the drug's target is absent, so it cannot work.

## What makes CMML an 'overlap' neoplasm rather than pure MDS or pure MPN?

It combines myeloproliferative features (monocytosis, big spleen, sometimes a high white count) with myelodysplastic ones (dysplasia and cytopenias), in the same clone.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/haematology/mds-mpn-overlap-cmml-jmml-and-atypical-cml/)

## Elsewhere in DurgiPedia

- [Myelodysplastic neoplasms](https://durgical.com/en/general-pathology/myelodysplastic-neoplasms/)
- [Myeloproliferative neoplasms: overview](https://durgical.com/en/general-pathology/myeloproliferative-neoplasms-overview/)
- [Chronic myeloid leukaemia](https://durgical.com/en/general-pathology/chronic-myeloid-leukaemia/)
- [Maturation of monocytes and lymphocytes](https://durgical.com/en/histology/maturation-of-monocytes-and-lymphocytes/)
- [Monocyte and macrophage](https://durgical.com/en/immunology/monocyte-and-macrophage/)
- [Neurofibroma, NF1 and MPNST](https://durgical.com/en/general-pathology/neurofibroma-nf1-and-mpnst/)

## Connections

## Related 7

- [Myeloproliferative neoplasms and myelodysplasia: too much or made badly](https://durgical.com/en/haematology/myeloproliferative-neoplasms-and-myelodysplasia-too-much-or-made-badly/)
- [High lymphocytes or monocytes: reactive, MBL/CLL or CMML?](https://durgical.com/en/haematology/high-lymphocytes-or-monocytes-reactive-mbl-cll-or-cmml/)
- [A high or low white count: which cell, and is it mature?](https://durgical.com/en/haematology/a-high-or-low-white-count-which-cell-and-is-it-mature/)
- [Chronic leukaemias: CML versus CLL (and hairy cell leukaemia)](https://durgical.com/en/haematology/chronic-leukaemias-cml-versus-cll/)
- [A big spleen, and life without one](https://durgical.com/en/haematology/a-big-spleen-and-life-without-one/)
- [Stem cell transplantation: autologous or allogeneic, and what can go wrong](https://durgical.com/en/haematology/stem-cell-transplantation-autologous-or-allogeneic-and-what-can-go-wrong/)
- [Eosinophilia: parasites, allergy, drugs or a neoplasm?](https://durgical.com/en/haematology/eosinophilia-parasites-allergy-drugs-or-a-neoplasm/)

## Related conditions 5

- [Myelodysplastic syndromes](https://durgical.com/en/conditions/myelodysplastic-syndromes/)
- [Chronic myeloid leukaemia](https://durgical.com/en/conditions/chronic-myeloid-leukaemia/)
- [Essential thrombocythaemia and primary myelofibrosis](https://durgical.com/en/conditions/essential-thrombocythaemia-and-primary-myelofibrosis/)
- [Acute leukaemia (AML and ALL)](https://durgical.com/en/conditions/acute-leukaemia/)
- [Sideroblastic anaemia](https://durgical.com/en/conditions/sideroblastic-anaemia/)

## In Pharmacology 6

- [Azacitidine](https://durgical.com/en/pharmacology/azacitidine/)
- [Decitabine](https://durgical.com/en/pharmacology/decitabine/)
- [Hydroxycarbamide](https://durgical.com/en/pharmacology/hydroxycarbamide/)
- [Ruxolitinib](https://durgical.com/en/pharmacology/ruxolitinib/)
- [Imatinib](https://durgical.com/en/pharmacology/imatinib/)
- [Luspatercept](https://durgical.com/en/pharmacology/luspatercept/)

[← All of haematology](https://durgical.com/en/haematology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: [Myelodysplastic/Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version](https://www.cancer.gov/types/myeloproliferative/hp/mds-mpd-treatment-pdq) (National Cancer Institute, 2025); [Childhood Acute Myeloid Leukemia Treatment (PDQ®)–Health Professional Version](https://www.cancer.gov/types/leukemia/hp/child-aml-treatment-pdq) (National Cancer Institute, 2025); [Myelodysplastic Syndrome](https://www.ncbi.nlm.nih.gov/books/NBK534126/) (StatPearls (NCBI Bookshelf), 2022).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/haematology/mds-mpn-overlap-cmml-jmml-and-atypical-cml/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/haematology/mds-mpn-overlap-cmml-jmml-and-atypical-cml/
